STAT+: Federal health quality research grants worth $109 million ended early

STAT PlusPolitics Federal health quality research grants worth $109 million ended early With two months left in fiscal year, AHRQ has spent only 4% of its appropriated funds Manage alerts for this article Email this article Share this article By Anil OzaJuly 22, 2026 General Assignment Reporter Anil Oza[email protected]Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Dozens of researchers funded by the federal Agency for Healthcare Research and Quality received notices last week that they would not receive future installments of funding for their ongoing research grants. While frustrating, the development was largely not a surprise to these researchers, many of whom had been waiting months for renewed funding or been unable to get explanations as to why the funding spigots had run dry from staffers at the agency. The notices punctuated nearly a year of uncertainty for health services researchers funded by AHRQ and left those who lost funding concerned about the future of their field. AcademyHealth, a professional organization representing health services researchers, has confirmed at least 78 grants worth $200 million have been affected. In all, those grants had $109.2 million in funding remaining, it estimated.Advertisement Grant recipients were told in a letter of “non-award” that “AHRQ is adjusting its discretionary health services research award portfolio in order to better prioritize agency resources towards the above-mentioned priorities to best serve the interests of the Federal Government,” according to one such letter reviewed by STAT. The letter states the agency is prioritizing research on patient safety, antibiotic resistance, AI, long Covid, nutrition, and understanding autism, among others. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+. Already have an account? Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%! Request A Quote Request A Quote Savings start at 25%! 2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+. Subscribe Log In HHS, Policy, research, STAT+ Submit a correction requestReprints Anil Oza General Assignment Reporter Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Newsletter The latest updates in federal health agencies, research institutes, and U.S. policy Recommended Insurance July 22, 2026 STAT Plus: More workers hate their jobs, but keep them for the health insurance Politics July 21, 2026 Trump administration says it’s deferring $1B in Medicaid payments to California and Minnesota Advertisement D.C. Diagnosis July 21, 2026 STAT Plus: Rare disease drugmakers try to avoid Trump price cuts Health July 21, 2026 STAT Plus: Advocates say federal funding is being cut from groups fighting HIV First Opinion July 21, 2026 How a controversial rule could hurt the NIH’s ability to manage risk Subscriber Picks